Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

18.2%

2 terminated/withdrawn out of 11 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

55%

6 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3

4(40.0%)

N/A

3(30.0%)

Phase 4

2(20.0%)

Phase 2

1(10.0%)

10Total

Phase 3(4)

N/A(3)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT05180305Unknown

A Study to Assess Mitomic Prostate Test for Prostate Cancer Screening

Role: lead

NCT03674658Not ApplicableCompleted

Propafenone in the Treatment of Atrial Fibrillation

Role: lead

NCT03401502Not ApplicableCompleted

A TSHRN1201 Sub-study-To Evaluate the Effects of add-on Ranolazine on Exercise Tolerance and Angina Frequency

Role: lead

NCT02685904Phase 3Terminated

A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis

Role: collaborator

NCT02294942Phase 3Completed

Extended-Release RANCAD in the Patients With Stable Angina Pectoris

Role: lead

NCT02432937Phase 3Completed

Corever in the Treatment of Hypertension

Role: lead

NCT01614366Phase 2Completed

DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension

Role: lead

NCT02058446Phase 4Completed

PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

Role: lead

NCT02368093Not ApplicableCompleted

Efficacy Study of Dextromethorphan to Treat Rheumatoid Arthritis

Role: collaborator

NCT01612078Phase 3Terminated

Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis Patients

Role: lead

NCT01375322Phase 4Completed

ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria

Role: lead

All 11 trials loaded